Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Abstract LB-223: Examination of intra-assay variability in a commercial ctDNA NGS assay with triplicate clinical plasma and pooled normal samples

Daniel Stetson, Brian Dougherty, Ambar Ahmed, Barrett Nuttall, Tristan J. Lubinski, Fakhera Afshar, Amelia Raymond, Carl Barrett

Cancer Res (2018) 78 (13_Supplement): LB-223.

https://doi.org/10.1158/1538-7445.AM2018-LB-223

Published: 01 July 2018

View article titled, Abstract LB-223: Examination of intra-assay variability in a commercial ctDNA NGS assay with triplicate clinical plasma and pooled normal samples

Journal Articles

Abstract LB-249: Examination of analytical factors impacting concordance of plasma-tumor testing by next-generation sequencing (NGS)

Daniel Stetson, Brian Dougherty, Ambar Ahmed, Tristan Lubinski, Aleksandra Markovets, Kenneth Thress, Robert McEwen, Gaia Schiavon, David Whitston, Barrett Nuttall, J. Carl Barrett

Cancer Res (2017) 77 (13_Supplement): LB-249.

https://doi.org/10.1158/1538-7445.AM2017-LB-249

Published: 01 July 2017

View article titled, Abstract LB-249: Examination of analytical factors impacting concordance of plasma-tumor testing by next-generation sequencing (NGS)

Journal Articles

Abstract 240: Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

Alvaro Avivar-Valderas, Robert McEwen, Amir Taheri-Ghahfarokhi, Ambar Ahmed, Daniel Stetson, Brian Dougherty, Marcello Maresca, Kevin Hudson, Francisco Cruzalegui

Cancer Res (2016) 76 (14_Supplement): 240.

https://doi.org/10.1158/1538-7445.AM2016-240

Published: 15 July 2016

View article titled, Abstract 240: Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

Journal Articles

Abstract 641: Use of conditional reprogramming to develop and characterize cell cultures from patient-derived xenograft (PDX) models of human lung and ovarian cancer

Alexandra Borodovsky, Travis J. McQuiston, Brian Dougherty, Ambar Ahmed, David Whitston, Daniel Stetson, Gretchen K. Hubbard, Sharon S. Challberg, Brian A. Pollok, Celina M. D’Cruz

Cancer Res (2016) 76 (14_Supplement): 641.

https://doi.org/10.1158/1538-7445.AM2016-641

Published: 15 July 2016

View article titled, Abstract 641: Use of conditional reprogramming to develop and characterize cell cultures from patient-derived xenograft (PDX) models of human lung and ovarian cancer

Journal Articles

Abstract 1706: Whole exome sequencing of pre and post treatment diffuse large B cell lymphoma reveals the mutation spectrum of the relapse/refractory patient population

Danielle Greenawalt, Kate Byth, Zhongwu Lai, Justin Johnson, Ambar Ahmed, Brian Dougherty, Kenneth Thress, Michael Zinda, Winnie S. Liang, John Carpten, Stephen Fawell, J. Carl Barrett

Cancer Res (2015) 75 (15_Supplement): 1706.

https://doi.org/10.1158/1538-7445.AM2015-1706

Published: 01 August 2015

View article titled, Abstract 1706: Whole exome sequencing of pre and post treatment diffuse large B cell lymphoma reveals the mutation spectrum of the relapse/refractory patient population

Journal Articles

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Cancer Res (2015) 75 (12): 2489–2500.

https://doi.org/10.1158/0008-5472.CAN-14-3167

Published: 14 June 2015

View article titled, Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Includes: Supplementary data

NARROW

Abstract LB-223: Examination of intra-assay variability in a commercial ctDNA NGS assay with triplicate clinical plasma and pooled normal samples

Abstract LB-249: Examination of analytical factors impacting concordance of plasma-tumor testing by next-generation sequencing (NGS)

Abstract 240: Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

Abstract 641: Use of conditional reprogramming to develop and characterize cell cultures from patient-derived xenograft (PDX) models of human lung and ovarian cancer

Abstract 1706: Whole exome sequencing of pre and post treatment diffuse large B cell lymphoma reveals the mutation spectrum of the relapse/refractory patient population

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Email alerts

AACR Journals

Abstract LB-223: Examination of intra-assay variability in a commercial ctDNA NGS assay with triplicate clinical plasma and pooled normal samples

Abstract LB-249: Examination of analytical factors impacting concordance of plasma-tumor testing by next-generation sequencing (NGS)

Abstract 240: Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

Abstract 641: Use of conditional reprogramming to develop and characterize cell cultures from patient-derived xenograft (PDX) models of human lung and ovarian cancer

Abstract 1706: Whole exome sequencing of pre and post treatment diffuse large B cell lymphoma reveals the mutation spectrum of the relapse/refractory patient population

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only